These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7171969)

  • 1. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer.
    Higley B; De Mello J; Oakes DJ; Giles GR
    Br J Surg; 1982 Dec; 69(12):699-701. PubMed ID: 7171969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.
    Sjølin KE
    Urol Res; 1982; 10(5):245-8. PubMed ID: 7164220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary levels of pseudouridine in patients with psoriasis determined by high-performance liquid chromatography.
    Nagayo K; Way BH
    Arch Dermatol Res; 1982; 274(3-4):335-8. PubMed ID: 7165377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
    Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
    Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of pseudouridine and creatinine in untreated urine by ion-pair liquid chromatography with diode-array ultraviolet detection.
    Palmisano F; Rotunno T; Guerrieri A; Zambonin PG
    J Chromatogr; 1989 Aug; 493(1):35-43. PubMed ID: 2778020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody.
    Itoh K; Mizugaki M; Ishida N
    Clin Chim Acta; 1989 May; 181(3):305-15. PubMed ID: 2758683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary pseudouridine as a tumor marker in patients with small cell lung cancer.
    Tamura S; Fujii J; Nakano T; Hada T; Higashino K
    Clin Chim Acta; 1986 Jan; 154(2):125-32. PubMed ID: 3006946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of urinary pseudouridine by high-performance liquid chromatography.
    Yamamoto T; Higashino K; Tamura S; Fujioka H; Amuro Y; Hada T
    Anal Biochem; 1988 May; 170(2):387-9. PubMed ID: 2840004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
    Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
    Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
    Kvist E; Sjølin KE; Iversen J
    Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
    Tu Z; Xu S; Wu M
    Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of urinary pseudouridine by micellar electrokinetic capillary chromatography.
    Evans MD; Perrett D; Lunec J; Herbert KE
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():527-33. PubMed ID: 9293307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
    Tamura S; Amuro Y; Nakano T; Fujii J; Moriwaki Y; Yamamoto T; Hada T; Higashino K
    Cancer; 1986 Apr; 57(8):1571-5. PubMed ID: 2418945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
    Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
    Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, quantitative high-performance liquid column chromatography of pseudouridine.
    Kuo KC; Gehrke CW; McCune RA; Waalkes TP; Borek E
    J Chromatogr; 1978 May; 145(3):383-92. PubMed ID: 659524
    [No Abstract]   [Full Text] [Related]  

  • 17. Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion.
    Honda I; Itoh K; Mizugaki M; Sasaki T
    Tohoku J Exp Med; 1999 Jun; 188(2):133-8. PubMed ID: 10526874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the age dependency of the creatinine-related pseudouridine excretion in children's urine by high-performance liquid chromatography.
    Assmann B; Haas HJ
    J Chromatogr; 1988 Dec; 434(1):202-8. PubMed ID: 3243814
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary pseudouridine excretion in myelomatosis.
    Sørensen SH; Brown DA; Cooper EH; Kelly KA; MacLennan IC
    Br J Cancer; 1985 Dec; 52(6):863-6. PubMed ID: 3907686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
    Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.